• The connection between skin, gut and brain: new insights for diagnosis and treatment

    News about the skin-gut-brain axis: Innovative findings on disease mechanisms promise advances in diagnosis and therapy.

  • The association between total, animal-based, and plant-based protein intake and cognitive decline in older adults

    These findings suggest protein intake does not benefit cognitive function in older adults. Negative associations may relate to protein food sources.

  • Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV-Related Cirrhosis: A Landmark Analysis

    In patients with HBV-related cirrhosis, the aspirin-treated group showed a significantly lower risk of HCC than the untreated group, whereas the risk of GI bleeding was significantly higher in the aspirin-treated group.

  • Glutamine prevents diarrhea in colorectal cancer patients undergoing chemotherapy or chemoradiotherapy: a meta-analysis

    Randomized controlled trials of glutamine in the prevention of chemotherapy-associated diarrhea of colorectal cancer were retrieved from the Cochrane Library, Pubmed, EMBASE, CNKI, and Wanfang by computer up to August 1, 2024.

  • Sociodemographic Bias in Large Language Model–Assisted Gastroenterology

    In this study, we examined whether sociodemographic details were associated with differences in LLM-generated recommendations for gastroenterology presentations.

  • Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990–2021

    The global burden of metabolic diseases is increasing, but estimates of their impact on primary liver cancer are uncertain. We aimed to assess the global burden of primary liver cancer attributable to metabolic risk factors, including high body mass index (BMI) and high fasting plasma glucose (FPG) levels, between 1990 and 2021.

  • Fermented pickles improve gut microbiota and immune profile in women in a community trial in rural Pakistan

    In a prospective 12-week intervention trial, we evaluated the effects of six different plant-based fermented pickles (~ 50 g/day) on clinical, inflammatory, and gut microbiota parameters in a cohort of women (n = 230) in a rural setting with a high prevalence of undernutrition.

  • Semaglutide shows promise in MASH

    The phase 3 ESSENCE trial, published in NEJM, reports that once-weekly semaglutide 2.4 mg achieves significant histologic improvements in patients with MASH and stage F2–F3 fibrosis.

  • Generation and Phenotypic Analysis of the IL-10RAR Mouse Model

    Very-early-onset inflammatory bowel disease (VEO-IBD) is a form of IBD that manifests in infants and young children, with a significant proportion of them carrying interleukin 10 receptor alpha (IL-10RA) mutations.

  • Drastic increase in gastrointestinal malignancies among young adults

    Gastrointestinal tract cancer is increasing at an unprecedented rate among younger adults worldwide, with colorectal cancer in 15- to 19-year-olds rising by 333%, for example.

  • Distinct gastroesophageal reflux characteristics in preterm-born infants fed human milk versus formula: insights for clinical practice on outcomes

    Despite the pathophysiology caused by acid-GER events, human milk properties may provide better adaptation and modulation of neurosensory and neuromotor responses upon esophageal provocation.

  • Clinical insights into diabetic gastroparesis: gastric scintigraphy-based diagnosis and treatment outcomes

    This study highlighted the role of the GCSI in assessing and monitoring gastroparesis, particularly in resource-limited settings. Diabetic GP differs in clinical presentation and management from other types of GP.

  • Preventing Unnecessary Endoscopic Retrograde Cholangiopancreatography in Patients With Spontaneous Bile Duct Stone Passage: A Systematic Review and Meta-Analysis

    A watch-and-wait approach in patients with high probability of spontaneous CBDS passage could avoid unnecessary ERCP and related adverse events in these patients. Further large-scale, prospective studies are needed to validate these findings.

  • Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn’s Disease: Opportunities and Challenges

    This narrative review summarizes the current knowledge on using intestinal ultrasound (IUS) in patients with Crohn’s disease. The benefits and challenges of using IUS in clinical trials and real-world practice are discussed.

  • Oral Microbiome Dysbiosis Is Associated With Precancerous Lesions and Disorders of Upper Gastrointestinal Tract: A Population-Based Study

    Dysbiosis of the salivary microbiota was observed in subjects with gastroesophageal reflux symptoms (GERSs) alone, as well as in those with combined conditions such as GERS and esophagitis, or esophagitis and Barrett's esophagus.

  • Anal Cancer Incidence Among Women With a History of Cervical Cancer by Age and Time Since Diagnosis

    A total of 85 524 women diagnosed with cervical cancer between 1975 and 2021 were identified, with a follow-up of 822 630 person-years. Among these women, 64 cases of anal cancer were diagnosed.

  • The reality of care for older patients with Crohn's disease and ulcerative colitis

    A review summarises the current state of care for older people with IBD – from treatment response and symptoms to quality of life and psychological stress.

  • Genomic characterization of normal and aberrant human milk production

    This study provides a comprehensive human milk transcriptomic catalog and highlights that MFG could serve as a useful biomarker for milk transcriptome analysis, offering insights into the genetic factors influencing milk production.

  • Microbiome-driven therapies: from gut health to precision medicine

    Gut microbiomes influence intestinal inflammation, metabolic disorders, or cancer, and enable new therapies like probiotics or faecal transplants.

  • Interview: Prof. Rimassa on rare tumours, real needs, and a clinical systemic overview

    New therapies for liver, pancreatic and biliary tract tumours offer promising prospects. But innovation also means ensuring equitable access, quality of life and multidisciplinary care pathways.

  • 1 |
  • 2 |
  • 3 |
  • 4 |
  • 5 |
  • 6 |